Publication | Closed Access

Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models

NanomedicinePlatinum ResistanceTherapeutic NanomaterialsMedicinePolymer-drug ConjugateGynecologyOvarian Cancer ModelsNanoparticle Co-deliveryTumor TargetingCancer TreatmentOncologyRadiation OncologyOvarian Cancer